Two lawsuits this year are threatening to cost Johnson & Johnson a total of $127 million. The 130-year-old healthcare consumer products company looks set to appeal both verdicts - but even as it prepares to do so, more plaintiffs are coming forward with lawsuits of their own.
In fact, the company has stated that it currently faces more than 1,400 similar cases, each alleging that talc in Johnson & Johnson Baby Powder can cause ovarian cancer when applied to the genital area. Perhaps even more serious, many of these lawsuits also declare that the multinational company has failed to warn its customers of the risks associated with talc for decades.
Johnson & Johnson has faced these kinds of claims for years, but it wasn't until earlier this year that they gained credibility. A groundbreaking study published in the journal Epidemiology showed that regularly applying talc-based baby powder to the genitals could increase the risk of developing ovarian cancer by almost 40 percent.
If you are a regular user of baby powder and you were diagnosed with ovarian cancer, contact a personal-injury lawyer at The Finnell Firm. Robert Finnell is a Johnson & Johnson cancer claim attorney in Rome, Georgia who will evaluate your case in a free initial consultation. Call 866-464-4017 to get started.
Let's take a closer look at the case against Johnson & Johnson:
What Is in Baby Powder?
Baby powder is a dry powder regularly used on the skin to absorb moisture and reduce friction and odor. It is most often composed of corn starch or talc, in which case it is known as talcum powder.
Until a few decades ago, talcum powder generally contained asbestos, a hazardous substance known to cause cancer. Federal guidelines were drafted in the 1970s to ensure talc-based products marketed to the general public were asbestos-free.
That measure went a long way for keeping people safe from cancer. However, studies show it didn't completely solve the problem; talc itself, though it no longer contains asbestos, could be almost as risky to use on a regular basis.
Did Johnson & Johnson Mislead Its Customers?
This question was at the center of both of the lawsuits the company lost earlier this year. Johnson & Johnson was ordered to pay a combined $127 million in damages to plaintiffs who blamed their ovarian cancer on the use of talcum powder as a feminine hygiene product.
In both cases, juries agreed with the argument that Johnson & Johnson had a responsibility to inform the public of the risks associated with regular use of its talc-based Baby Powder, and failed to do so. And in both cases, the damages associated with that negligence were substantial.
The company, meanwhile, has continued to deny there may be risks associated with using its products. In an official statement, Johnson & Johnson said the verdict "goes against 30 years of studies by medical experts around the world that continue to support the safety of cosmetic talc."
Should You Sue Johnson & Johnson for Damages?
Bringing a lawsuit against Johnson & Johnson is not as simple as claiming that you have been made ill or injured by one of the company's products. To succeed in such a claim you or your personal-injury lawyer must prove the company was negligent.
There are four elements to making a successful medical product liability claim. You or your Johnson & Johnson cancer claim lawyer will have to show that:
● The defendant owed the plaintiff a duty of care;
● The defendant breached its duty of care;
● The plaintiff suffered injuries; and
● The breach of the defendant's duty of care was the cause of the plaintiff's injuries.
If you were diagnosed with cancer after using Johnson & Johnson's talc-based Baby Powder, contact The Finnell Firm. A Rome personal-injury lawyer will review your case and help you proceed in making a claim.
Personal-injury attorney Robert Finnell has been successful in representing injured clients in cases involving medical product liability, workers' compensation, catastrophic injuries such as brain and
burn injuries, and other types of claims. Call 866-464-4017 to schedule a free initial consultation.